Home
>
National Drug Code (NDC)
>
Denavir
Denavir - 50816-624-01 - (penciclovir)
Drug Information of Denavir
| Product NDC: | 50816-624 |
| Proprietary Name: | Denavir |
| Non Proprietary Name: | penciclovir |
| Active Ingredient(s): | 10 mg/g & nbsp; penciclovir |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Denavir
| Product NDC: | 50816-624 |
| Labeler Name: | New American Therapeutics, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020629 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101229 |
Package Information of Denavir
| Package NDC: | 50816-624-01 |
| Package Description: | 1 TUBE in 1 CARTON (50816-624-01) > 1.5 g in 1 TUBE |
NDC Information of Denavir
| NDC Code | 50816-624-01 |
| Proprietary Name | Denavir |
| Package Description | 1 TUBE in 1 CARTON (50816-624-01) > 1.5 g in 1 TUBE |
| Product NDC | 50816-624 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | penciclovir |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20101229 |
| Marketing Category Name | NDA |
| Labeler Name | New American Therapeutics, Inc |
| Substance Name | PENCICLOVIR |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
